Eterna Therapeutics
ERNA
9 hedge funds and large institutions have $3.31M invested in Eterna Therapeutics in 2017 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 0 closing their positions.
13% more funds holding
Funds holding: 8 → 9 (+1)
31% less capital invested
Capital invested by funds: $4.79M → $3.31M (-$1.48M)
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NSIM
North Star Investment Management
Chicago,
Illinois
|
+$237K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$79K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AIC
AWM Investment Company
New York
|
-$158K |
| 2 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
-$79K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
NSIM
1
North Star Investment Management
Chicago,
Illinois
| $1.26M | +$237K | +3 | +18% |
|
|
AIC
2
AWM Investment Company
New York
| $1.21M | -$158K | -2 | -10% |
|
|
EAM
3
Eagle Asset Management
St Petersburg,
Florida
| $302K | -$79K | -1 | -17% |
|
4
Renaissance Technologies
New York
| $194K | – | – | – |
|
5
Geode Capital Management
Boston,
Massachusetts
| $89K | – | – | – |
|
|
CA
6
Callahan Advisors
Houston,
Texas
| $79K | – | – | – |
|
7
Vanguard Group
Malvern,
Pennsylvania
| $71K | – | – | – |
|
8
PNC Financial Services Group
Pittsburgh,
Pennsylvania
| $63K | – | – | – |
|
|
9
UBS Group
Zurich,
Switzerland
| $32K | +$79K | +1 | New |
|
10
BlackRock
New York
| $12K | – | – | – |
|
11
Barclays
London,
United Kingdom
| $1K | – | – | – |
|
|
LTFS
12
Ladenburg Thalmann Financial Services
Miami,
Florida
| $1K | – | – | – |
|
ERNA Hedge Fund Activity: Q4 2017 in Review
9 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Eterna Therapeutics (ERNA) for Q4 2017, worth a combined $3.31M — down 31% from $4.79M a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new ERNA positions and 0 closed out — a net gain of 1 holder — while 1 added to existing stakes and 2 trimmed.
The largest buyer was North Star Investment Management, adding an estimated $237K. The largest seller was AWM Investment Company, cutting an estimated $158K.
- 9 institutional investors held Eterna Therapeutics (ERNA) as of Q4 2017, up from 8 in Q3 2017.
- Funds reported $3.31M of Eterna Therapeutics stock for Q4 2017, down 31% quarter-over-quarter.
- 1 fund opened new Eterna Therapeutics positions in Q4 2017 and 0 closed out, a net change of +1 holder.
- The largest Eterna Therapeutics buyer in Q4 2017 was North Star Investment Management, an estimated $237K added.
- The largest Eterna Therapeutics seller in Q4 2017 was AWM Investment Company, an estimated $158K sold.
Based on aggregated 13F filings for Q4 2017.